Michael Griffin
Stock Analyst at Citigroup
(2.90)
# 1,380
Out of 4,829 analysts
13
Total ratings
80%
Success rate
20.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $132.69 | +20.58% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $34.75 | -59.71% | 1 | Mar 4, 2024 | |
| JLL Jones Lang LaSalle | Maintains: Neutral | $178 | $240.52 | -25.99% | 3 | Sep 18, 2023 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $14.94 | +13.79% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $2.37 | +89.87% | 2 | May 19, 2023 |
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $132.69
Upside: +20.58%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $34.75
Upside: -59.71%
Jones Lang LaSalle
Sep 18, 2023
Maintains: Neutral
Price Target: $178
Current: $240.52
Upside: -25.99%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $14.94
Upside: +13.79%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $2.37
Upside: +89.87%